Rong Wang Yuchen Yang Wei-Wu Ye Jianxing Xiang Songan Chen Wei-Bin Zou Xiao-Jia Wang Tianhui Chen Wen-Ming Cao
10.3389/fonc.2020.588080
Front Oncol
2021 Feb 9;10:588080.
ngs tmb biomarker breast cancer immunotherapy molecular monitoring
CC BY
https://pubmed.ncbi.nlm.nih.gov/33634015/
Case Reports
PMC7900143
33634015
Case Report: Significant Response to Immune Checkpoint Inhibitor Camrelizumab in a Heavily Pretreated Advanced ER+/HER2- Breast Cancer Patient With High Tumor Mutational Burden
2021